Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic regimens in leprosy.

S R Pattyn1

  • 1Universiteit Antwerpen (UIA), Dept. Genesskunde en Instituut voor Tropische Geneeskunde, Antwerpen.

Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|January 1, 1990
PubMed
Summary

Advances in leprosy treatment, particularly with new drugs, significantly shorten treatment duration and reduce relapses. Public perception of leprosy as a treatable disease is crucial for early diagnosis and reduced transmission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical significance of herpes simplex virus in the lower respiratory tract of critically ill patients.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2002
Same author

Monkeypoxvirus infections.

Revue scientifique et technique (International Office of Epizootics)·2001
Same author

[To live happily, we live secretly. The knowledge of virus reservoirs is essential for the fight against infectious diseases].

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·2000
Same author

[Yersinia pestis. Bacteriology].

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·1999
Same author

Comparison of two PCRs for detection of Mycobacterium ulcerans.

Journal of clinical microbiology·1998
Same author

[Infectious diseases, the veritable pandora's box].

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·1997

Area of Science:

  • Medical Microbiology
  • Pharmacology
  • Epidemiology

Background:

  • Leprosy, caused by Mycobacterium leprae, has seen significant advancements in understanding its bacteriology, pathology, and treatment over the past 30 years.
  • Early research, including Shepard's work on M. leprae multiplication in mouse foot pads, laid the groundwork for modern treatment strategies.

Purpose of the Study:

  • To review the progress in leprosy treatment over the last three decades.
  • To highlight the impact of new bactericidal drugs on treatment duration and relapse rates.
  • To emphasize the need for improved understanding and management of leprosy complications and the importance of public perception.

Main Methods:

  • Review of scientific literature and studies on leprosy treatment.
  • Analysis of the impact of new antimicrobial agents on Mycobacterium leprae.
  • Evaluation of factors influencing patient presentation, disease transmission, and endemicity.

Main Results:

  • Studies demonstrate that leprosy treatment can be considerably shortened with effective drug regimens.
  • Introduction of highly bactericidal drugs for M. leprae offers potential for improved treatment outcomes, provided toxicity and antagonism are managed.
  • Addressing public fear and promoting the view of leprosy as a treatable disease is essential for early detection and reduced transmission.

Conclusions:

  • Modern pharmacological approaches can significantly reduce the duration of leprosy treatment and minimize relapse rates.
  • Continued research and public education are vital for managing leprosy complications like reversal reactions and erythema nodosum leprosum.
  • Achieving a public health situation comparable to tuberculosis requires a shift in perception, leading to earlier diagnosis, reduced transmission, and effective rehabilitation in endemic areas.

Related Experiment Videos